The Future of Clinical Psychology

Author(s):  
David H. Barlow ◽  
Jenna R. Carl

In this chapter, we speculate on near to immediate future trends in clinical psychology and make ten predictions in the broad areas of training, diagnosis and assessment, and treatment. These include: (1) an increased focus on competencies in training; (2) the implications of evidence-based practice as a new major focus of training; (3) changes in the accreditation of training programs; (4) a move to dimensional conceptions of diagnosis; (5) clinical outcomes assessment as an integral part of practice, as well as a more individual focus in clinical research; (6) the increasing recognition and dissemination of psychological treatments; (7) the end of single-diagnosis psychological treatment manuals; (8) the development of drugs that specifically enhance the mechanisms of action of psychological treatments; (9) an expanded role for technology in service delivery; and (10) a clearer delineation of the terms “psychological treatments,” referring to interventions directed at psychopathology and pathophysiology in the context of our health-care delivery system, and, “psychotherapy,” increasingly based on data from positive psychology, but directed at enhancing personal adjustment and growth.

Author(s):  
David H. Barlow ◽  
Jenna R. Carl

In this chapter, we speculate on near to immediate future trends in clinical psychology and make ten predictions in the broad areas of training, diagnosis and assessment, and treatment. These include: (1) an increased focus on competencies in training; (2) the implications of evidence-based practice as a new major focus of training; (3) changes in the accreditation of training programs; (4) a move to dimensional conceptions of diagnosis; (5) clinical outcomes assessment as an integral part of practice, as well as a more individual focus in clinical research; (6) the increasing recognition and dissemination of psychological treatments; (7) the end of single-diagnosis psychological treatment manuals; (8) the development of drugs that specifically enhance the mechanisms of action of psychological treatments; (9) an expanded role for technology in service delivery; and (10) a clearer delineation of the terms “psychological treatments,” referring to interventions directed at psychopathology and pathophysiology in the context of our health-care delivery system, and, “psychotherapy,” increasingly based on data from positive psychology, but directed at enhancing personal adjustment and growth.


2016 ◽  
Vol a4 (2) ◽  
pp. 112-128 ◽  
Author(s):  
Allison M. Waters ◽  
Richard T. LeBeau ◽  
Michelle G. Craske

Experimental psychopathology has elucidated mechanisms underlying various forms of psychopathology and has contributed to the continuous updating and generation of mechanistically-focused and evidence-based psychological treatments. Clinical psychology is an applied field of psychology concerned with the assessment and treatment of psychological disorders and behavioral problems. Despite the notable commonality in their focus upon psychological dysfunction, conceptual frameworks that guide their integration are surprisingly scarce. Clinical science and practice would benefit greatly from the combined strengths of each discipline. In this review, we begin by defining experimental psychopathology and clinical psychology, we present arguments for greater integration between them, and we propose a model to guide the integration of experimental psychopathology-informed science into clinical practice, illustrating the relevance of the model by drawing upon the seminal research on fear conditioning and extinction and other experimental paradigms.


1986 ◽  
Vol 16 (2) ◽  
pp. 47-56 ◽  
Author(s):  
Lourens Schlebusch

Clinical psychology is developing into an integral part of modern health care delivery systems as evidenced by its role in the establishment of services in clinical psychology in general hospitals, training programmes in medical psychology, and the increased teaching of medically applied psychology in medical schools. This extended role of clinical psychology is discussed against the background of a subspecialization in psychonephrology. The aim is to illustrate the development of psychological treatment for chronically ill patients with end-stage renal disease, in the context of a developing country with a multi-ethnic society.


2016 ◽  
Vol 5 (04) ◽  
pp. 4524
Author(s):  
Abdullah Shaikh Farooque ◽  
Md. Azharuddin Ismail Atar*

Medicinal plants are being widely used, either as single drug or in combination in health care delivery system. Indian Sarsaparilla, Hemidesmus indicus (Family: Asclepiadaceae) is a commonly known Indian Medicinal Plant, which is widely recognized in traditional systems of Medicine. It contains various phytoconstituents belonging to the category glycosides, flavonoids, tannins, sterols and volatile oils. It has been reported as useful in biliousness, blood diseases, dysentery, diarrhea, respiratory disorders, skin diseases, syphilis, fever, leprosy, leucoderma, leucorrhoea, itching, bronchitis, asthma, eye diseases, epileptic fits in children, kidney and urinary disorders, loss of appetite, burning sensation, dyspepsia, nutritional disorders, ulcer and rheumatism. Several studies are being carried towards its activities like analgesic, anti-inflammatory, antiulcer, hepatoprotective, antioxidant and helicobactericidal properties. In our study we have evaluated antacid activity of sariva (Anantmool) by using In-Vitro method, i.e. ANC (Acid Neutralizing Capacity). This evaluation was done by comparing the ANC of sariva macerated & powdered drug with water as blank & standard drug i.e. NaHCO3. Based on this In-Vitro experiment, we can conclude that, the macerated & powdered drug of sariva (Anantmool) evaluated in this study, varied in potency as measured in terms of their ANC. These results having ** i.e. P < 0.01 & Passed the normality test. However, the present study being in-vitro, the effects of antacid may vary In-Vitro; individual variations also contribute to the ultimate effectiveness of as antacid.        


2021 ◽  
pp. 1-11
Author(s):  
Maxi Weber ◽  
Sarah Schumacher ◽  
Wiebke Hannig ◽  
Jürgen Barth ◽  
Annett Lotzin ◽  
...  

Abstract Several types of psychological treatment for posttraumatic stress disorder (PTSD) are considered well established and effective, but evidence of their long-term efficacy is limited. This systematic review and meta-analysis aimed to investigate the long-term outcomes across psychological treatments for PTSD. MEDLINE, Cochrane Library, PTSDpubs, PsycINFO, PSYNDEX, and related articles were searched for randomized controlled trials with at least 12 months of follow-up. Twenty-two studies (N = 2638) met inclusion criteria, and 43 comparisons of cognitive behavioral therapy (CBT) were available at follow-up. Active treatments for PTSD yielded large effect sizes from pretest to follow-up and a small controlled effect size compared with non-directive control groups at follow-up. Trauma-focused treatment (TFT) and non-TFT showed large improvements from pretest to follow-up, and effect sizes did not significantly differ from each other. Active treatments for comorbid depressive symptoms revealed small to medium effect sizes at follow-up, and improved PTSD and depressive symptoms remained stable from treatment end to follow-up. Military personnel, low proportion of female patients, and self-rated PTSD measures were associated with decreased effect sizes for PTSD at follow-up. The findings suggest that CBT for PTSD is efficacious in the long term. Future studies are needed to determine the lasting efficacy of other psychological treatments and to confirm benefits beyond 12-month follow-up.


Author(s):  
Shuhei Nomura ◽  
Yuta Tanoue ◽  
Daisuke Yoneoka ◽  
Stuart Gilmour ◽  
Takayuki Kawashima ◽  
...  

AbstractIn the COVID-19 era, movement restrictions are crucial to slow virus transmission and have been implemented in most parts of the world, including Japan. To find new insights on human mobility and movement restrictions encouraged (but not forced) by the emergency declaration in Japan, we analyzed mobility data at 35 major stations and downtown areas in Japan—each defined as an area overlaid by several 125-meter grids—from September 1, 2019 to March 19, 2021. Data on the total number of unique individuals per hour passing through each area were obtained from Yahoo Japan Corporation (i.e., more than 13,500 data points for each area). We examined the temporal trend in the ratio of the rolling seven-day daily average of the total population to a baseline on January 16, 2020, by ten-year age groups in five time frames. We demonstrated that the degree and trend of mobility decline after the declaration of a state of emergency varies across age groups and even at the subregional level. We demonstrated that monitoring dynamic geographic and temporal mobility information stratified by detailed population characteristics can help guide not only exit strategies from an ongoing emergency declaration, but also initial response strategies before the next possible resurgence. Combining such detailed data with data on vaccination coverage and COVID-19 incidence (including the status of the health care delivery system) can help governments and local authorities develop community-specific mobility restriction policies. This could include strengthening incentives to stay home and raising awareness of cognitive errors that weaken people's resolve to refrain from nonessential movement.


BMJ Open ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. e040233
Author(s):  
Paola Gilsanz ◽  
Elizabeth Rose Mayeda ◽  
Chloe W Eng ◽  
Oanh L Meyer ◽  
M Maria Glymour ◽  
...  

ObjectiveThe role of spousal education on dementia risk and how it may differ by gender or race/ethnicity is unknown. This study examines the association between one’s own education separate from and in conjunction with spousal education and risk of dementia.DesignCohort.SettingKaiser Permanente Northern California (KPNC), an integrated health care delivery system.Participants8835 members of KPNC who were aged 40–55, married and reported own and spousal education in 1964–1973.Primary outcome measureDementia cases were identified through medical records from 1 January 1996 to 30 September 2017.MethodsOwn and spousal education was self-reported in 1964–1973 and each was classified as four indicator variables (≤high school, trade school/some college, college degree and postgraduate) and as ≥college degree versus <college degree. Age as timescale weighted Cox proportional hazard models adjusted for demographics and health indicators evaluated associations between participant education, spousal education and dementia risk overall and by gender and race/ethnicity.ResultsThe cohort was 37% non-white, 46% men and 30% were diagnosed with dementia during follow-up from 1996 to 2017 (mean follow-up=12.7 years). Greater participant education was associated with lower dementia risk independent of spousal education, demographics and health indicators. Greater spousal education was associated with lower dementia adjusting for demographics but became non-significant after further adjustment for participant education. The same pattern was seen for spousal education ≥college degree (not adjusting for participant education HRspousal education≥college degree=0.83 (95% CI: 0.76 to 0.90); adjusting for participant education HRspousal education≥college degree=0.92 (95% CI: 0.83 to 1.01)). These associations did not vary by gender or race/ethnicity.ConclusionIn a large diverse cohort, we found that higher levels of participant’s own education were associated with lower dementia risk regardless of spousal education. An inverse association between spousal education and dementia risk was also present, however, the effects became non-significant after adjusting for participant education.


Sign in / Sign up

Export Citation Format

Share Document